Rockland Trust CO Gilead Sciences, Inc. Transaction History

Rockland Trust CO

$2.01 Billion
Q3 2024

A detailed history of Rockland Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rockland Trust CO holds 4,945 shares of GILD stock, worth $457,808. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,945

Previous 4,978 0.66%

Holding current value

$457,808

Previous $341,000 21.41%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$66.59 - $83.99 $2,197 - $2,771	-33 Reduced 0.66%	4,945 $414,000
Q2 2024 Jul 23, 2024	BUY	$63.15 - $72.88 $29,743 - $34,326	471 Added 10.45%	4,978 $341,000
Q1 2024 Apr 11, 2024	SELL	$71.58 - $87.29 $4,939 - $6,023	-69 Reduced 1.51%	4,507 $330,000
Q4 2023 Jan 11, 2024	SELL	$73.27 - $83.09 $2,491 - $2,825	-34 Reduced 0.74%	4,576 $370,000
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $24,661 - $28,097	-319 Reduced 6.47%	4,610 $382,000
Q4 2022 Jan 24, 2023	SELL	$62.32 - $89.47 $74,908 - $107,542	-1,202 Reduced 19.61%	4,929 $423,000
Q1 2022 Apr 18, 2022	BUY	$57.92 - $72.58 $60,584 - $75,918	1,046 Added 20.57%	6,131 $364,000
Q4 2021 Jan 27, 2022	BUY	$64.88 - $73.64 $32,115 - $36,451	495 Added 10.78%	5,085 $369,000
Q3 2021 Oct 25, 2021	BUY	$67.69 - $73.03 $16,922 - $18,257	250 Added 5.76%	4,590 $321,000
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $48,110 - $52,567	758 Added 21.16%	4,340 $298,000
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $5,340 - $6,092	-89 Reduced 2.42%	3,582 $232,000
Q4 2020 Jan 04, 2021	SELL	$56.65 - $64.55 $6,571 - $7,487	-116 Reduced 3.06%	3,671 $214,000
Q3 2020 Oct 08, 2020	BUY	$62.1 - $78.08 $2,297 - $2,888	37 Added 0.99%	3,787 $239,000
Q2 2020 Jul 09, 2020	SELL	$72.34 - $84.0 $3,617 - $4,200	-50 Reduced 1.32%	3,750 $288,000
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $8,079 - $10,348	-129 Reduced 3.28%	3,800 $284,000
Q3 2019 Oct 11, 2019	BUY	$62.51 - $69.0 $245,601 - $271,101	3,929 New	3,929 $244,000
Q2 2018 Jul 06, 2018	SELL	$64.88 - $75.68 $177,187 - $206,682	-2,731 Closed	0 $0
Q1 2018 Apr 10, 2018	SELL	$72.84 - $88.8 $10,926 - $13,320	-150 Reduced 5.21%	2,731 $206,000
Q4 2017 Jan 11, 2018	SELL	$71.15 - $83.52 $14,230 - $16,704	-200 Reduced 6.49%	2,881 $206,000
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $222,170 - $263,333	3,081	3,081 $250,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockland Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Rockland Trust CO with notifications on news.

Account

Rockland Trust CO Gilead Sciences, Inc. Transaction History